Related Experiment Video
Updated: Aug 29, 2026

Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus
Published on: October 1, 2015
Viral hepatitis in the Canadian Inuit and First Nations populations
1Department of Medicine, University of Manitoba, Winnipeg, Canada. gminuk@cc.umanitoba.ca
Insights
Viral hepatitis, including hepatitis A (HAV), B (HBV), and C (HCV), is common in Canadian Inuit and First Nations. Outcomes for HBV and HCV appear more benign in these populations compared to non-Aboriginal Canadians when HIV and alcohol abuse are absent.
Area of Science:
- Public Health
- Infectious Diseases
- Epidemiology
Background:
- Viral hepatitis, specifically hepatitis A (HAV), B (HBV), and C (HCV), represents a significant public health concern.
- Indigenous populations in Canada, including Inuit and First Nations, may experience disproportionately high rates of infectious diseases.
Purpose of the Study:
- To systematically review and synthesize published prevalence data for HAV, HBV, and HCV infections.
- To compare the prevalence of these viral hepatitis infections in Canadian Inuit and First Nations populations against non-Aboriginal Canadians.
Main Methods:
- Conducted a comprehensive search of the PubMed database.
- Reviewed all identified papers reporting data from seroepidemiological surveys in the target populations.
Main Results:
- High prevalence of anti-HAV positivity (75%-95%) in Inuit and First Nations, three times higher than non-Aboriginals.
- HBV infection prevalence is approximately 5% in Inuit (20x non-Aboriginals), with lower rates in First Nations similar to non-Aboriginals.
- HCV infection (anti-HCV) is more common in Inuit and First Nations (1%-18%) than non-Aboriginals (0.5%-2%), though viremia (HCV-RNA) is less frequent.
Conclusions:
- Viral hepatitis is highly prevalent among Canadian Inuit and First Nations populations.
- HBV and HCV infections appear to have more favorable outcomes in these populations when co-infections (HIV) and alcohol abuse are absent.
Objective:
To review published prevalence data regarding hepatitis A (HAV), B (HBV) and C (HCV) in Canadian Inuit and First Nations populations.
Methods:
PubMed database search and review of all papers describing data derived from seroepidemiological surveys.
Results:
The prevalence of anti-HAV positivity in Canadian Inuit and First Nations populations reported to date is high (range 75% to 95%) and approximately three times that of non-Aboriginal Canadians residing in the same communities. Among the Canadian Inuit, the prevalence of HBV infection is approximately 5%, or 20 times that of non-Aboriginal Canadians, while the risk of exposure to HBV is 25%, or five times higher. Regarding the First Nations population, preliminary data suggest the prevalences of HBV infection (0.3% to 3%) and exposure (10% to 22%) are similar to rates in non-Aboriginals residing in the same regions and participating in similar high risk activities. Serological evidence of HCV infection (anti-HCV) is more common in the Canadian Inuit and First Nations (1% to 18%) than the remainder of the Canadian population (0.5% to 2%); however, viremia (HCV-RNA positivity) is less common (less than 5% versus 75% of anti-HCV positive individuals, respectively).
Conclusions:
Viral hepatitis is common in the Canadian Inuit and First Nations populations. In the absence of coexisting human immunodeficiency virus infection and alcohol abuse, the outcomes of HBV and HCV appear to be more benign than in non-Aboriginal Canadians.
More Related Videos
Related Concept Videos
Viral Hepatitis I: Introduction
Hepatitis
Inhibitors of Viral Protein Synthesis
Infectious Diseases and Their Occurrence
Influenza
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...

